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Retmae from neonatal nuce exposed to prolonged hyperoxia (100% oxygen), show marked vasoproliferatlon Extracts of such retinae were chroma- 
tographed on a hepar]Il-Sepharos~ column and the absorbed material subjected to HPLC fractionation. Two components. approx. 10 and 18 kDa, 
respectively, were found to have angiogenic activity. which was higher than m correspondmg extracts from animals exposed to air. Both fractions 
and an addmonal 5 kDa component reacted with an antibody to basic fibrohlast growth factor (bFGF) and showed higher levels in hyperoxra 
The data suggest that hyperoxia activates angiogemc factors belonging to the heparin bmdmg famtly 
Angtogenests; Ftbroblast growth factor; Hyperoxia: Polypepttde: Retma 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Angiogenesis, the outgrowth of new blood 
capillaries, is a fundamental process in the development 
of tissues and organs during embryogenesis, tissue 
regeneration and wound healing [I]. It involves several 
complex phenomena, the resolution of the basal mem- 
brane, migration and proliferation of endothelial cells 
which develop vessel sprouts that eventually form 
capillary loops [2]. Abnormal angiogenesis can be pro- 
nounced in some pathological states, such as 
rheumatoid arthritis, cancer and certain retinopathies 
(proliferative diabetic retinopathy, retinal vein throm- 
bosis and retinopathy of prematurity (31). 
2.1. Polypeptides and chemrcals 
Recombinant bFCF (E. co/r] was purchased from Boehringer- 
Mannhetm. Protem and peptide standards used for column calibra- 
tion were from KabiVttrum AB, Stockholm, Sweden (human growth 
hormone) and from Sigma. The chromatographic material, heparin- 
Sepharose and Sephadex G-25 (PD-IO), were obtained from Phar- 
mafia, Uppsala, Sweden. Rat monoclonal anti-bFGF antibodies were 
a gift from Dr Andrew Baird, Dept of La Jolla, CA, USA. All other 
chemicals and solvents were of analytical grade. 
2,.2. Preparation of animals 
Angiogenesis can also be induced in the eyes of 
newborn animals, including mice, by exposure to 
hyperoxia during the first week of life 141. This was 
confirmed in the present paper which describes an at- 
tempt to recover and characterize angiogenic factors 
from retinae of hyperoxic mice. Chromatographic frac- 
tions were tested for angiogenic activity in the chick 
embryo chorioallantoic membrane. The fractions were 
also tested for immunogenic basic fibroblast growth 
factor (bFGF) which is a heparin binding growth fac- 
tor, with mitogenic activity on endothelial cells and 
with angiogenic activity [5,6]. Originally isolated from 
nervous tissue [7], bFGF is known to be produced in 
several tissues, among those the retina [5]. Basic FGF 
is a polypeptide of an apparent molecular mass of 
about 18 kDa [81. 
Litters of lo-15 newborn NMRI albino mice (Alab, Stockholm, 
Sweden), younger than 15 h were exposed to 100% oxygen for 5 days 
and then kept in air for 10 more days. Newborn mice maintamed in 
air for 15 days served as controls. At the end of the 15-day period 
animals of both groups were anaesthetized with a lethal dose of 
mebumal injected intraperitoneally and perfused with ice-cold PBS 
(phosphate-buffered sahne) from the left heart ventricle. The eyes 
were enucleated and the retinae removed without delay and im- 
mediately frozen and stored at -70°C until further processing. Some 
animals were, subsequent to the PBS perfusion, injected with India 
mk from the left heart ventricle in order to visualize the ocular vessels 
141. 
2.3. Purrfieufion procedures 
Correspondence address: F. Nyberg, Department of Pharmacology, 
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The tissues were homogenized in 1 :M acetic acid (10 ml/g tissue) 
and heated to 90°C for 15 min. Following cooling on ice and cen- 
trifugation (20 min at 10000 x g) the extract was collected and direct- 
ly applied onto a 2 ml column of heparin-Sepharose, previously 
equilibrated in 1 M acetic acid. After sample application the column 
was washed with 10 ml of 1 M acetic acid and eluted wtth 2.5 ml 3 M 
NaCl. The eluate was subsequently desalted on a prepacked Sephadex 
G-25 column (PD-IO) with 1 M acetic acid as eluent. The 
polypeptide-containing fraction was lyophilized and redissolved in 
200-300 pl of 20 mM Trts-HCI, pH 7.4. The reconstituted material 
was further purified by HPLC-gel filtration. In these experiments a 
Pharmacia/LKB instrument equipped with an Uhropac TSK G-3000 
SW column (7.5 x 600 mm) was used. This column operated at a flow 
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rate of 0.5 ml/min and fractions of 0.5 ml were collected and 
lyophllized for further analyst,. 
2.4. Assa_v for angrogenrc actrvltv 
Peptide-containing fractions obtamed from the HPLC- 
purification were tested for anglogenlc activity on the chick embryo 
chorloallantoic membrane (CAM). The CAhls of &day-old ex- 
planted chick embryos were used [9]. Peptide-contammg and control 
fractions (collected In glass tubes) were thoroughly mIxed with Elvax, 
an ethylene/vinyl acetate copolymer prepared according to Langer 
and Folkman [lo], dissolved m dichloromethane and dried to pellet,, 
3 mm In diameter. The pellets were then placed on the CAhl of the 
explanted chlcken embryos. The vessel architecture around the pellet 
was evaluated 5 days later and quantified according to the method 
given by Vu et al. [l I]. In brief, the anglogenic response was scored 
according to a 5 grade scale. e g. grade 0 = no angiogemc response. 
to grade 4 = very pronounced ‘spoke-wheel‘ effect on the leaseIs con- 
verging to the pellet. The ratio between the observed grade of 
anglogenesIs and the maximum attainable <core designated the 
angiogenic coefflclent 1s thus a figure between 0 and 1 
2.5. Radrormrnunoassyv 
The radloimmunoacsay (RIA) for bFGF used antlbodies raised in 
rabbits against human bFGF,_zd Nhlch are upeciflc for the FGF,o_z,l 
sequence [12]. Their crosveactlvlty with acidic FGF IS lcqs than 1%. 
“‘I-labelled bFGF \+as used as tracer. All Incubation\ \$ere perform- 
ed in Eppendorf tubes at 4°C and lasted for 18 h. The antIbodIes 
were diluted (1 : 10000) in 10 mM Na-phosphate buffer (pH 7.4) con- 
taining 0. I % gelatin. 0.82% NaCl and 0 93% EDTA (RIA-buffer). 
Lyophllized HPLC-separated samples were redl$solved In 500 pl 
methanol/O.1 M HCI (1 : 1). The reaction mxture contained a 25 ~1 
aliquot of sample or standard, 100 ,uI antIserum dilution and 100 ,uI 
labelled peptide (5000-6000 cpm In RIA-buffer). All mcubations 
were performed m Eppendorf tubes at 3’C and lacted for 48 h. 
Followmg incubation, 100 pl calf serum (Glbco, Scotland) and subse- 
quently 1 ml 15% polyethylene glycol 6000 \vere added to each vial. 
The samples were left to stand at 4°C for 30 mln before centrifuga- 
tion in a Beckman Microfuge B (2 min at 10000 rpm). The super- 
natants were decanted and the pellets taken for countmg in a 
gamma-counter. The detection limit of the radlolmmunoa\say was 
500 fmol/tube and 50% of tracer blnding was obvxved at 
50 fmol,/tube. The coefficient of interausay variation \vas X.4%. 
3. RESULTS 
The choice of acidic pH for the extraction of the 
angiogenic polypeptides was based on several ex- 
periments, in which different pHs were tried. Extrac- 
tion at neutral pH resulted in large amounts of peptides 
and proteins with affinity for the heparin-Sepharose gel 
(results not shown). The acetic acid extraction combin- 
ed with the affinity chromatography resulted in 2 or 3 
small UV-absorbing, presumably peptide components 
particularly in the oxygen-exposed animals, separable 
by HPLC gel filtration (Fig. 1). The peptides in the 
fractions 3 l-32 and 35-36, respectively corresponding 
to the highest peaks in Fig. 1 (oxygen-exposed 
animals), showed an angiogenic coefficient of 0.5 in the 
CAM assay, while the corresponding fractions from the 
control animals showed an angiogenic coefficient of 
0.25. From calibration runs with peptide and protein 
standards the apparent molecular masses of these frac- 
tions were estimated to be approximately 18 and 
10 kDa, respectively. The 18 kDa fraction 
76 
Fig. I. UV-absorbance folIowIng HPLC-gel flltratlon of mouse 
retinal extracts bound to the heparm-Sepharose column. The retmae 
material sac collected from mxe exposed to (a) oxygen and (b) air. 
The HPLC column (TSK-G3000 SW) wa\ eluted with 20 ml\1 Tris- 
HCl, pH 7.8, maIntaming a flo\\ rate of 0.5 ml/‘min 
chromatographed almost identically with bFGF stan- 
dard. In the radioimmunoassay for bFGF both frac- 
tions were active. A third component eluted at about 
5 kDa molecular mass (Fig. 2). 
b) 
Fig. 2 The dlstrlbution of bFGF-hhe lmmunoreactivlty followmg 
HPLC-gel fdtration (TSKG3000 SW) of the heparin-Sepharose 
adsorbed fraction from mouse retma collected during exposure to (a) 
oxygen and (b) air. 
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4. DISCUSSION 
Ashton [4] has described the vasoproliferative effects 
of hyperoxic treatment on the retinal vessels in 
newborn animals of several species, including mice. 
The same vascular effects of hyperoxia could be 
reproduced in the present study (not shown). 
Michaelson [13] has proposed ‘a factor or factors’ that 
regulate the normal development of the normal 
vascularization of the retina, and later Ashton and co- 
workers [14] suggested a ‘vasoformative’ factor induc- 
ing the retinal neovascularization not only in ex- 
pwimental situations but also in conditions with 
proliferative retinopathies. Since FGF has been 
detected in the retina [ 151, this growth factor may be 
one of those postulated. Our results show that the in- 
creased proliferation induced by hyperoxia is accom- 
panied by an increase in a heparin binding angiogenic 
factor and an increased production of polypeptides 
reacting in a radioimmunoassay for bFGF. More work 
is needed to establish whether the biologic activity is in- 
deed due to a bFGF-like molecule. Further studies are 
also needed to establish the time relationship between 
exposure to hyperoxia, the vascular proliferation and 
the increased production of angiogenic polypeptides. 
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